Serb Pharmaceuticals

SERB Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of prescription medicines for rare and life-threatening conditions. They generate revenue through the sale of their proprietary drugs and strategic partnerships. Founded in 1991, SERB has a rich history of innovation, including the acquisition of BTG Specialty Pharmaceuticals in 2019, which expanded their portfolio significantly. The company is dedicated to addressing unmet medical needs and improving patient outcomes globally.

Recent Posts by Serb Pharmaceuticals

1-10 of 10